Kirk Allen Coleman - Chief Financial Officer at TFF Pharmaceuticals, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Kirk Allen Coleman since 03 Jun 2025

Reported holdings for Kirk Allen Coleman in TFF Pharmaceuticals, Inc.

Form 4 holding Chief Financial Officer

TFF Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
45,859
Estimated value
$17,958
Report date
03 Jul 2024
Price
$0.3916
Ownership
Direct
Form 4 holding Chief Financial Officer

TFF Pharmaceuticals, Inc.

Security class
Restricted stock units
Shares / value
10,600
Estimated value
$4,151
Report date
18 Apr 2024
Price
$0.3916
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding Chief Financial Officer

TFF Pharmaceuticals, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
10,184
Estimated value
Report date
03 Jul 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Kirk Allen Coleman in TFF Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .